{
    "organizations": [],
    "uuid": "2db1c19df9420624defbcab9157f811d4aa3f15a",
    "author": "",
    "url": "https://cn.reuters.com/article/%E6%8A%95%E8%A1%8C%E8%A7%82%E7%82%B9%EF%BC%9ABellicum-Pharmaceuticals%E7%9B%AE%E6%A0%87%E4%BB%B7%E4%BB%8E26%E4%B8%8B%E8%B0%83%E8%87%B322-idCNL4S1PQ41K",
    "ord_in_thread": 0,
    "title": "投行观点：Bellicum Pharmaceuticals目标价从26下调至22美元--Guggenheim",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 31, 2018 / 10:32 AM / 更新于 7 hours ago 投行观点：Bellicum Pharmaceuticals目标价从26下调至22美元--Guggenheim",
    "published": "2018-01-31T12:30:00.000+02:00",
    "crawled": "2018-01-31T16:35:11.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "更新于",
        "hour",
        "ago",
        "pharmaceuticals目标价从26下调至22美元",
        "guggenheim"
    ]
}